ANATARA LIFESCIENCES LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.039 AUD | -7.14% |
|
-4.88% | +77.27% |
| Apr. 09 | Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial | MT |
| Feb. 28 | Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chart calendar Anatara Lifesciences Ltd
7303d0a1b2ebe1b3ccb61ae65.mJOODV30RcfI38opmpBwSVfyF1p85F4T9gQDqCa9wa8.zvzrT2y3Ma_9q5tc28MqGzOnQj82nDQmj01g8Hn89f_P9986B810sby4-g~9552715cafddac1942ce143f76100f71
Upcoming events on Anatara Lifesciences Ltd
Past events on Anatara Lifesciences Ltd
| 2024-02-27 07:52 pm | Q2 2024 Earnings Release |
| 2024-01-23 05:36 pm | December 2023 Sales and Revenue Release - Activities Report |
| 2023-11-09 06:30 pm | Annual General Meeting |
| 2023-10-18 | Irritable Bowel Syndrome Stage 1 Clinical Trial Results Call |
| 2023-08-23 07:33 pm | Q4 2023 Earnings Release |
| 2023-07-18 06:20 pm | June 2023 Sales and Revenue Release - Activities Report |
| 2023-04-19 06:07 pm | March 2023 Sales and Revenue Release - Activities Report |
| 2023-02-23 05:08 pm | Interim 2023 Earnings Release |
| 2023-01-11 04:21 pm | December 2022 Sales and Revenue Release - Activities Report |
| 2022-12-11 | Shareholders Meeting |
| 2022-11-10 | Annual General Meeting |
| 2022-08-28 | FY 2022 Earnings Release |
| 2022-07-31 07:02 pm | June 2022 Sales and Revenue Release - Activities Report |
| 2022-04-28 | March 2022 Sales and Revenue Release - Activities Report |
| 2022-02-23 05:59 pm | Interim 2022 Earnings Release |
| 2022-01-26 | December 2021 Sales and Revenue Release - Activities Report |
| 2021-12-08 | Gastro Congress |
| 2021-11-16 | Microbiome Connect Conference |
| 2021-11-15 | Annual General Meeting |
| 2021-11-03 | USA Microbiome R&D and Business Collaboration Forum |
Annual results
| Fiscal Period | June | 2019 |
|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,50 1,70 -11.51% |
|
EBITDA Million AUD | Released Forecast Spread | -2,99 -2,90 -3.04% |
|
EBIT Million AUD | Released Forecast Spread | -3,01 -3,10 2.88% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - |
|
Net income Million AUD | Released Forecast Spread | -2,87 -2,60 -10.32% |
|
EPS AUD | Released Forecast Spread | -0,06 -0,05 -12.38% |
| Announcement Date | 26/08/19 |
More events
Past sector events for Anatara Lifesciences Ltd
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
- Stock Market
- Equities
- ANR Stock
- Calendar Anatara Lifesciences Ltd
